Keystone Dental has announced the appointment of Russ Bonafede as their new CEO. Russ Bonafede assumed responsibilities on 8/14/2018 and will succeed Michael Kehoe, who has stepped down but will remain in a consulting capacity for the next six months.

Russ Bonafede has nearly 30 years of experience predominantly focused in the implantable medical device industry. Russ served as President of Zest Dental Solutions prior to joining Keystone Dental. During that time, he successfully built a commercial organization at Zest, was pivotal to two acquisitions/integrations, and part of a successful sale of the business in March to the private-equity firm BC Partners. Previously Russ Bonafede served as President of Henry Schein Orthodontics, a top five player in the fixed orthodontic market and as Vice-President of Global Marketing for both Zimmer Dental and Biomet 3i before those organizations merged. Russ holds a B.S. Degree in marketing from SUNY Plattsburgh where he graduated cum laude and earned an MBA from San Diego State University.

“Keystone Dental has a significant legacy in the implant market and remains one of the larger independent companies in the sector. In collaboration with our new private equity partners, Accelmed, I look forward to accelerating Keystone’s position through a combination of organic and new business development initiatives”, noted Russ Bonafede.

Keystone Dental is an oral healthcare company dedicated to the delivery of breakthrough dental surgical and prosthetic technology. Headquartered in Burlington, Massachusetts with manufacturing and distribution facilities in Irvine, California, Keystone markets its products worldwide. The company’s product portfolio includes proprietary offerings such as Genesis – The Biomimetic Implant System™, the TILOBEMAXX™, PrimaConnex® and Prima Plus™ Implant Systems, the DynaMatrix® Extracellular Membrane, and the DynaBlast® and DynaGraft® bone graft substitutes.

For more information, refer to www.keystonedental.com